Literature DB >> 11388961

Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials.

J Geddes1, G Goodwin.   

Abstract

Background The increasing use of the methods of evidence-based medicine to keep up-to-date with the research literature highlights the absence of high-quality evidence in many areas in psychiatry. Aims To outline current uncertainties in the maintenance treatment of bipolar disorder and to describe some of the decisions involved in designing a large simple trial. Method We describe some of the strategies of evidence-based medicine, and how they can be applied in practice, focusing specifically on the area of bipolar disorder. Results One of the key clinical uncertainties in the treatment of bipolar disorder is the place of maintenance drug treatments and their relative efficacy. A large-scale study, the Bipolar Affective DISORDER: Lithium Anticonvulsant Evaluation (BALANCE) trial, is proposed to compare the effectiveness of lithium, valproate and the combination of lithium and valproate. Conclusions Providing reliable answers to key clinical questions in psychiatry will require new approaches to clinical trials. These will need to be far larger than previously appreciated and will therefore need to be collaborative ventures involving front-line clinicians.

Entities:  

Year:  2001        PMID: 11388961

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  4 in total

1.  Clinical trial design: horses for courses.

Authors:  John R Geddes
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

Review 2.  Treatment research in bipolar disorder: issues and recommendations.

Authors:  Ross J Baldessarini
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Long-term prophylaxis in bipolar disorder.

Authors:  Matthew J Taylor; Guy M Goodwin
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 4.  Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy.

Authors:  Kathryn J Macdonald; L Trevor Young
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.